Brian Cahill - Dec 18, 2023 Form 4 Insider Report for EAGLE PHARMACEUTICALS, INC. (EGRX)

Role
Chief Financial Officer
Signature
/s/ Brian Cahill
Stock symbol
EGRX
Transactions as of
Dec 18, 2023
Transactions value $
-$2,152
Form type
4
Date filed
12/20/2023, 04:34 PM
Previous filing
Mar 2, 2023
Next filing
Jan 9, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EGRX Common Stock Tax liability -$2.15K -452 -0.94% $4.76 47.4K Dec 18, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The disposition reported on this Form 4 represents shares withheld by the Issuer to cover the tax liability upon the vesting of time-based restricted stock units previously granted and does not represent a discretionary transaction by the Reporting Person.